Currently, he is mainly devoted to the application of new sGC stimulators and activators in cardiovascular and other diseases, such as arteriosclerosis, benign prostatic hyperplasia, kidney disease, and systemic sclerosis (SSc), a rare autoimmune disease. This evidence concerns the gene SGCB and systemic sclerosis.